|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Operating loss | |||||
| Other income (expense), net: | |||||
| Interest expense | |||||
| Interest income and other income (expense), net | |||||
| Other income (expense), net | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Net loss per share of common stock and pre-funded warrants, basic | |||||
| Net loss per share of common stock and pre-funded warrants, diluted | |||||
| Weighted-average shares used in computing basic net loss per share | |||||
| Weighted-average shares of common stock and pre-funded warrants outstanding, diluted |
Loading...
